Myrtelle Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| rAAV-Olig001-ASPA Gene Therapy for Treatment of Children With Typical Canavan Disease (NCT04833907) | Myrtelle Inc. | 2021-04-01 |
Track Myrtelle Inc. automatically
Every clearance here is in the API, with alerts when new ones post.